drugset / Trial / NCT03025113

Efficacy and Safety of the Combination of Ketoprofen and Cyclobenzaprine in Osteomuscular Treatment

NCT03025113

Phase 3 Completed 416 enrolled EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the safety and efficacy of an association with one anti-inflammatory and one muscle relaxant agent compared to the one muscle relaxant agent isolated in the treatment of osteomuscular pain in adults.

Timeline

Start
2018-03-08
Primary completion
2019-11-29
Completion
2020-03-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoprofen Small molecule Oral
Comparator cyclobenzaprine Small molecule Oral